Filters

Denis Poddubnyy, Swen Jacki, Maren Sieburg, Jan Brandt-Juergens, Anne-Katrin Weber, Laura Spiller, Hildrun Haibel, Mikhail Protopopov, Joachim Listing, Fabian Proft, Uta Kiltz, Joachim Sieper, Maryna Verba, Valeria Rios Rodriguez, Burkhard Muche, Murat Torgutalp, Judith Rademacher

Annals of the rheumatic diseases 2024;83(5):599-607

Free Full Text

Abstract

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

Matthew L Stoll, Randy Q Cron

Current opinion in rheumatology 2017;28(5):537-43

Free Full Text

Abstract

Ochronotic arthropathy in the context of spondyloarthritis differential diagnosis: a case-based review.

Rositsa Karalilova, Zguro Batalov, Tsvetelina Kostova, Anastas Batalov

Rheumatology international 2022;42(12):2277-2282

Full Text

Abstract

Quantifying and predicting the effect of anti-TNF therapy on axSpA-related fatigue: results from the BSRBR-AS registry and meta-analysis.

Neil Basu, Gary J Macfarlane, Gareth T Jones, Maira Karabayas, Linda E Dean, Joanna Shim

Rheumatology (Oxford, England) 2021;59(11):3408-3414

Free Full Text

Abstract

Results: 1 – 15 / 22

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Spondylarthropathies""[mesh_terms]

Radiosynoviorthesis of medium-sized joints with rhenium-186-sulphide colloid: a review of the literature.

Balneotherapy in spondyloarthropathy: A systematic review.

Gastrointestinal lesions associated with spondyloarthropathies.

Osteoporosis and osteoarthritis, rheumatoid arthritis and spondylarthropathies.

The United States National Health and Nutrition Examination Survey and the epidemiology of ankylosing spondylitis.

Probiotics in arthralgia and spondyloarthropathies in patients with inflammatory bowel disease. Prospective randomized trials are necessary.

Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease.

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.

Lifestyle modification and inflammation in people with axial spondyloarthropathy-A scoping review.

Importance of intestinal microenvironment in development of arthritis. A systematic review.

Alkaptonuria presenting with ochronotic spondyloarthropathy.

Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial.

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

Ochronotic arthropathy in the context of spondyloarthritis differential diagnosis: a case-based review.

Quantifying and predicting the effect of anti-TNF therapy on axSpA-related fatigue: results from the BSRBR-AS registry and meta-analysis.

Results for
""Spondylarthropathies""[mesh_terms]